Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > this is what a good bio therapeutic
View:
Post by Duster340 on Apr 27, 2022 2:13pm

this is what a good bio therapeutic

company should look like (my best kept secret still time to get in guys) LYRA

Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 14/22 Apr 12/22 Perceptive Advisors Llc Indirect Ownership Common Stock P - Open market or private purchase  5,924,170 $4.22
Apr 14/22 Apr 12/22 Nbvm Gp, Llc Indirect Ownership Common Stock P - Open market or private purchase  765,010 $4.22
Apr 14/22 Apr 12/22 Nbvm Gp, Llc Indirect Ownership Common Stock P - Open market or private purchase  527,806 $4.22
Apr 14/22 Apr 12/22 Nbvm Gp, Llc Indirect Ownership Common Stock P - Open market or private purchase  1,076,851 $4.22
Apr 14/22 Apr 12/22 Anderson Edward T Direct Ownership Common Stock P - Open market or private purchase  118,483 $4.22
Apr 14/22 Apr 12/22 Anderson Edward T Indirect Ownership Common Stock P - Open market or private purchase  765,010 $4.22
Apr 14/22 Apr 12/22 Anderson Edward T Indirect Ownership Common Stock P - Open market or private purchase  527,806 $4.22
Apr 14/22 Apr 12/22 Anderson Edward T Indirect Ownership Common Stock P - Open market or private purchase  1,076,851 $4.22
Apr 13/22 Apr 12/22 Waksal Harlan Direct Ownership Common Stock P - Open market or private purchase 236,966 $4.22
Comment by davgro on Apr 27, 2022 3:04pm
Yo Dust Pan, why are you posting this on the ATE board.  Are you implying that ATE is not a "good bio therapeutic" company.  And if so, then why did you buy 7000+ shares of ATE just last week at $0.76 and $0.77. I really think your meds aren't working and you need a "good bio therapeutic" medication.  Are you not tired of embarrasssing yourself with these ...more  
Comment by themagicbox on Apr 27, 2022 4:14pm
Pure comedy haha. I have had that tool on ignore for years so I never see his comments till someone "quotes" him. He still makes the same turd comments as always. When you're oblvious like dumpster here, self awareness is nonexistant. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities